Advertisement

Picture Berlin Partner Voices from Berlin-Brandenburg Georg Duda 650x200px
Organisation › Details

Bristol-Myers Squibb (BMS) (Group)

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram. Celgene and Juno Therapeutics are wholly owned subsidiaries of Bristol-Myers Squibb Company. In certain countries outside the U.S., due to local laws, Celgene and Juno Therapeutics are referred to as, Celgene, a Bristol Myers Squibb company and Juno Therapeutics, a Bristol Myers Squibb company. *

 

Period Start 1989-10-04 merged
  Predecessor Bristol-Myers (Group)
Product Industry pharmaceutical
     
Region Region New York, NY
  Country United States (USA)
  Street 430 East 29th Street
14th Floor
  City 10016 New York, NY
  Tel +1-212-546-4000
    Address record changed: 2020-12-02
     
Basic data Employees H: 10,001 to 50,00 (2018-12-31)
  Currency USD
  Annual sales 22,561,000,000 (revenue, total, consolidated (2018) 2018-12-31)
  Profit 4,947,000,000 (2018-12-31)
  Cash 6,911,000,000 (2018-12-31)
     
    * Document for �About Section�: 
     
   
Record changed: 2022-03-11

Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x200px

More documents for Bristol-Myers Squibb (BMS) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BioPharm Amercia 2022 Boston 650x300px




» top